Related Experiment Video
Updated: Nov 2, 2025

07:51
Isolation of Leukocytes from the Murine Tissues at the Maternal-Fetal Interface
Published on: May 21, 2015
17.6K
[IMMUNE DISORDERS AND THEIR ROLE IN ABORTION].
K Gotsiridze1, N Kintraia1, T Gogia1
1Tbilisi State Medical University, JSC Chachava Clinic, Georgia.
Georgian Medical News
|June 9, 2021
Summary
Recurrent pregnancy loss is linked to immune system dysregulation. Elevated natural killer cell activity and specific interleukins like TNF-α and IL-6 are observed after early pregnancy termination.
Area of Science:
- Immunology
- Reproductive Medicine
Background:
- Recurrent miscarriage affects a significant number of women.
- The immunological factors contributing to pregnancy termination are not fully understood.
Purpose of the Study:
- To investigate the relationship between specific immunological parameters and pregnancy termination.
- To identify the role of immune system shifts in early pregnancy loss.
Main Methods:
- Enzyme immunoassay was used to measure peripheral blood natural killer (pNK) cells (CD16+), interleukins (IL2, IL6, IL10), TNF-α, VEGF, and γ-INF.
- Study included 28 women with a history of 2 or more miscarriages, examined post-termination (up to 12 weeks).
- A control group of 20 healthy non-pregnant women was included for comparison.
Main Results:
- Women with recurrent miscarriage showed significantly increased pNK - CD16+ cell activity (27.5%, p<0.01) compared to controls.
- Elevated levels of TNF-α (39.0 pg/ml vs. 27.5 pg/ml, p<0.05) and IL6 (28.5 pg/ml vs. 13.95 pg/ml, p<0.01) were observed post-termination in women with miscarriage history.
- These findings suggest immune system dysregulation in women experiencing recurrent pregnancy loss.
Conclusions:
- Immune system dysregulation, characterized by increased pNK cell activity and elevated pro-inflammatory cytokines (TNF-α, IL6), is associated with first-trimester pregnancy termination.
- These immunological shifts may play a crucial role in the etiology of recurrent miscarriage.
Related Concept Videos
Development of Immunocompetence
542
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
542
Immunodeficiency Diseases
1.3K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
1.3K
Autoimmune Disorders
978
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
978
Teratogenicity
3.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.3K
Humoral Immune Responses
79.1K
Overview
79.1K
Transcytosis of IgG
3.4K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
3.4K

